Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

Clinical trial NCT02864758 · COMPLETED

Trial details

NCT number: NCT02864758
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2016-09-08
Primary completion: 2018-09-30
Enrollment: 99999

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.